Select a Region North America

EVERSANA COMPLETE Commercialization® – Executing on 4 Key Performance Indicators

EVERSANA’s Rohit Sood, Executive Vice President, COMPLETE Commercialization shares the four key performance indicators we focus on with every EVERSANA COMPLETE Commercialization program – Speed, Agility, Consistency and Risk Management.  

Check out our whitepaper, CHALLENGING TRADITION: The argument for integrated commercialization to improve operational agility, to learn more about what occurs when pharmaceutical companies: 

  • lean into evolution and adopt an innovative mindset, 
  • leverage a fully integrated commercialization model to drive operational excellence, 
  • harness the energy and momentum in an efficient and accessible package and  
  • turn away from fixed and sluggish structures and toward more efficient partnerships for success. 


Executive Vice President, EVERSANA COMPLETE Commercialization®

Rohit leads the EVERSANA COMPLETE Commercialization® business which consists of a world-class global life sciences commercialization team who drives the execution of our partnered multi-TA portfolio. He is responsible for shaping the commercial structure,…